Live Trump tariffs updates: POTUS digs in as markets sink OTC Markets Grey - Delayed Quote • USD (ALEAF) Follow 0.0000 0.0000 (0.00%) As of March 28 at 4:00:00 PM EDT. Market Open. Related Mutual Fund News MariMed Promotes Ryan Crandall to Chief Commercial Officer NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews Each Betty’s Caramelt Away Chew Uses Rich, Buttery Caramel, To Create Moments of MellowNORWOOD, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural cannabis chews handcrafted to fit a variety of needs, is expanding its lineup with the introduction of delicious caramel chews: Betty’s Caramelt Away. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MariMed Launches Nature’s Heritage™ Flower in Illinois NORWOOD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has officially introduced its Nature’s Heritage™-branded cannabis flower, pre-rolls, and vapes in Illinois. This marks the first time the brand’s premium products are available in the state. The launch follows the late 2024 openning of MariMed’s Mt. Vernon, Illinois, cultivation facility. Nature’s Heritage products ar 1933 Industries Reports Second Quarter 2025 Financial Results VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its second quarter financial results ... MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the full year and three months ended December 31, 2024. CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients ... CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" ... MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its full year and fourth quarter financial results for the three and twelve months ended December 31st, 2024, before markets open on Monday, March 31st, 2025. Charlotte's Web Holdings Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.16 loss in FY 2023) Charlotte's Web Holdings ( TSE:CWEB ) Full Year 2024 Results Key Financial Results Revenue: US$49.7m (down 21% from FY... iAnthus Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results NEW YORK and TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the fourth quarter and year ended December 31, 2024. The Company’s Annual Report on Form 10-K (the “Annual Report”), which includes its audited consolidated financial statements for the year ended December 31, 2024 and t Auxly Cannabis Group Full Year 2024 Earnings: CA$0.014 loss per share (vs CA$0.045 loss in FY 2023) Auxly Cannabis Group ( TSE:XLY ) Full Year 2024 Results Key Financial Results Revenue: CA$122.3m (up 21% from FY 2023... CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025 SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 /CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ... Auxly Reports 2024 Fourth Quarter and Full Year Results: Achieves Record Sales and Profitability, Back Forty exits 2024 as the #1 Brand in Canada Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company in the cannabis products market, today released its financial results for the fourth quarter and full year ended December 31, 2024. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares ("Shares") and per Share amounts. Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year-ended December 31, 2024. AKITA Drilling And 2 Other Promising Penny Stocks On The TSX The Canadian market has been navigating a landscape of uncertainty, with recent tariff threats and political ambiguities influencing investor sentiment. Amidst these challenges, investors often look for opportunities that balance affordability with growth potential. Penny stocks, despite their somewhat outdated name, continue to offer intriguing possibilities for those seeking hidden value in smaller or newer companies. These stocks can present significant upside when backed by strong... AUXLY TO REPORT FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS ON MARCH 20, 2025 Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") announced today that it will report earnings results for its fourth quarter and full year ended December 31, 2024, on Thursday March 20, 2025, before the financial markets open. MariMed Inc (MRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion ... Despite a challenging retail environment, MariMed Inc (MRMD) achieves record full-year revenue and significant wholesale growth, while focusing on strategic market expansions. Q4 2024 MariMed Inc Earnings Call Q4 2024 MariMed Inc Earnings Call MariMed Reports Fourth Quarter and Full Year 2024 Earnings NORWOOD, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the fourth quarter and year ended December 31, 2024. MariMed CEO Jon Levine commented, “We’re pleased to report record revenues and improved adjusted EBITDA for MariMed. I continue to believe we own one of the strongest portfolios of cannabis brands in the ind MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware NORWOOD, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announced today it has completed its acquisition of First State Compassion Center (“FSCC”), the leading cannabis operator in Delaware, in accordance with the terms of the previously announced Omnibus Agreement entered into with FSCC in July 2023. The acquisition integrates FSCC’s cultivation and processing facilities, and two dispensari